9-AC: Halted Phase II trial development

Idec Pharmaceuticals Corp. (IDPH), San Diego, Calif. Product: 9-AC Business: Cancer Therapeutic category: Cytotoxic Target: Solid tumors Description: 9-aminocamptothecin chemotherapeutic Indication: ...